Online | In-person
Abstract Submission Deadline: May 15, 2024
Save on Registration: Before May 21, 2024
About
Conference Information
Experts
Speakers
Dates
Abstract
Abstract Submission
Review Process
Program
Scientific Program
Presentation Guidelines
Sponsors
Become a Sponsor
Exhibition
Venue
Contact
Register
Experts
Home
Experts
Experts speaking @ CGT-SUMMIT 2024
Alan M. Lambowitz
Professor
The University of Texas at Austin, TX
Rudolf Jaenisch
Professor
MIT, MA
Ula V. Jurkunas
Associate Professor of Ophthalmology
Harvard Medical School, MA
Daniel Getts
Chief Executive Officer
Myeloid Therapeutics, MA
Luis Pereira de Almeida
President
CNC UC, Portugal
Michael Chen
CEO & Co-founder
Great Bay Bio, Hong Kong
Lynne Frick
President & CEO
Cell X Technologies, OH
John Rossi
Vice President
Head of Translational Medicine CARGO Therapeutics, CA
Rachel Salzman
CEO
Armatus Bio, OH
Joseph Pekny
Co-Founder/CEO
Advanced Process Combinatorics Inc., IN
Deborah D. Ascheim
Chief Medical Officer
Rejuvenate Bio, CA
Irene Rombel
CEO and Co-founder
BioCurie, DE
Keiichi Fukuda
CEO
Heartseed, Japan
Michael Mehler
Director, Cell Therapy Supply Chain & Operations
Takeda Pharmaceuticals, MA
David McNally
Head of Viral Vector Technology
MassBiologics, MA
Chang Li
Assistant Professor
University of Washington, WA
Moritz von Stosch
Chief Innovation Officer
Datahow, Switzerland
Jason Criscione
Chief Scientific Officer
Enquyst Technologies, Inc., MA
Kira Gillett
Program Manager, Translational Science
FNIH, MD
Hiroshi Sugimoto
Associate Director
Takeda Development Center Americas Inc., MA
Kimberley Buytaert-Hoefen
Executive Director & Global Head of Regulatory Affairs
QPS LLC, DE
Amir Hefni
Chief Executive Officer
Resolution Therapeutics, UK
Xingxing Zang
Louis Goldstein Swan Chair in Cancer Research
Albert Einstein College of Medicine, NY
Yuechao Zhao
Director, R&D
Celularity Inc., NJ
Nick Lai
Senior Scientist
Regeneron Pharmaceuticals, NY
Larry Forman
Founder and CEO
CHO Plus, Inc., CA
Asaf Hellman
Professor
The Hebrew University, Israel
Anand Srivastava
Chairman and Cofounder
Global Institute of Stem Cell Therapy and Research (GIOSTAR), CA
Susan M. Faust
Patent Specialist
Hogan Lovells US LLP, DC
Ruby Tsai
CEO & Co-Founder
Applied StemCell, CA
Liping Yu
VP, Application
Applied Cells, CA
John Lu
President and CEO
HebeCell, MA
Alicia D. Henn
CSO
BioSpherix, Ltd., NY
Zeynep Guillemin
Senior Scientist
Voyager Therapeutics, MA
Parameswaran Hari
Chief Development Officer
Obsidian Therapeutics, MA
Tetsuya Yamagata
Chief Scientific Officer
Modalis Therapeutics Inc., MA
Jesse Kay
Business Development Manager
PROGEN Biotech Inc., AR
Demet (Dee) Sag
Founder
Genome2Life, MA
Greg Kunst
CEO
Aurion Biotech, WA
Jaspreet Khurana
Senior Director, mRNA Programming
Strand Therapeutics, MA
Michael Krohn
Executive Vice President
BRAIN Biotech AG, Germany
Erin Kimbrel
President
Astellas Institute for Regenerative Medicine, MA
Victor Hernandez
Chief Scientific Officer
Axovia Therapeutics Ltd, UK
Sally Gu
Senior Associate
Hogan Lovells US LLP, DC
Huiren Zhao
Principle Scientist
Amgen, CA
Stefan Braam
Founder and CTO
Cellistic, Belgium
Elisa Cuevas
Head of NPD
4basebio Discovery Ltd, UK
For regular updates bookmark
Global Cell & Gene Therapy Summit
website
